Role of nuclear medicine in clinical urology and nephrology
The application of radionuclide studies to nephrologic and urologic practice has reached a measurable degree of maturity during the past several years. In spite of this, the utilization of these techniques in many institutions in the United States continues to be far less frequent than one would expect from the clinical advantages. The aim of this editorial is to try to place the role of nuclear medicine in urology and nephrology in perspective. At the present time, in spite of the large number of renal agents that have been developed, there is no practical ideal radiopharmaceutical that can serve as a universal agent. Arbitrarily, one may reduce the chief armamentarium to only four radiopharmaceuticals; technetium-99m DTPA, I-131 OIH (orthoiodohippurate), technetium-99m glucoheptonate and technetium-99m DMSA. These agents are discussed with their relative advantages and disadvantages.
- Research Organization:
- Montefiore Medical Center, Bronx, NY
- OSTI ID:
- 7098238
- Journal Information:
- J. Nucl. Med.; (United States), Vol. 25:5
- Country of Publication:
- United States
- Language:
- English
Similar Records
Nuclear medicine in urology and nephrology
Nuclear renal imaging in acute pyelonephritis
Related Subjects
IODINE 131
SCINTISCANNING
KIDNEYS
TECHNETIUM 99
URINARY TRACT
UROGENITAL SYSTEM DISEASES
DIAGNOSIS
DTPA
GLUCOHEPTONATE
HIPPURAN
ISOMERIC NUCLEI
AMINO ACIDS
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BODY
CARBOXYLIC ACID ESTERS
CARBOXYLIC ACIDS
CHELATING AGENTS
CONTRAST MEDIA
COUNTING TECHNIQUES
DAYS LIVING RADIOISOTOPES
DIAGNOSTIC TECHNIQUES
DISEASES
DRUGS
ESTERS
HOURS LIVING RADIOISOTOPES
INTERMEDIATE MASS NUCLEI
IODINE ISOTOPES
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
NUCLEI
ODD-EVEN NUCLEI
ORGANIC ACIDS
ORGANIC COMPOUNDS
ORGANS
RADIOISOTOPE SCANNING
RADIOISOTOPES
RADIOPROTECTIVE SUBSTANCES
TECHNETIUM ISOTOPES
YEARS LIVING RADIOISOTOPES
550601* - Medicine- Unsealed Radionuclides in Diagnostics